Efficacy and safety of switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low-level viremia: a real-world 48-week extension studyZhongbin Li, Yunfei Jia, Jie Zhou et al.|Antimicrobial Agents and Chemotherapy|2025Cited by 2
Assessment of significant hepatic damage in young patients with chronic hepatitis B to initiate the antiviral treatment: The APLB scoreYifan Guo, Dong Ji, Yihui Rong et al.|Antiviral Research|2025Cited by 0